{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:09Z","timestamp":1787026509045,"version":"build-2736575974"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Hepatic lipid metabolism homeostasis is crucial for maintaining metabolic health, and its disruption is a central factor in the development of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD). Circular RNAs (circRNAs),a novel class of non-coding RNAs characterized by their covalently closed loop structures and remarkable stability, have emerged as key regulators of gene expression. Recent studies have revealed that circRNAs play significant roles in modulating critical hepatic lipid metabolism signaling pathways, including AMPK, mTOR, PPAR, and SREBP. This review systematically summarizes the latest advances in understanding how circRNAs influence these pathways through mechanisms such as acting as molecular sponges for microRNAs, interacting with proteins, and potentially encoding functional peptides. We critically evaluate the experimental models used in key studies, distinguishing between\n                    <jats:italic>in vitro<\/jats:italic>\n                    ,\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and clinical evidence, and discuss the context-dependent nature of circRNA function. Furthermore, the potential of circRNAs as diagnostic biomarkers and therapeutic targets for NAFLD and MASLD is discussed, highlighting their clinical relevance alongside a balanced assessment of the challenges facing clinical translation. By integrating current research findings, this review aims to provide a comprehensive theoretical foundation for elucidating the regulatory networks governing hepatic lipid metabolism and for developing innovative intervention strategies against metabolic liver diseases.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2026.1831613","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:10:15Z","timestamp":1781561415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["CircRNAs in hepatic lipid metabolism: regulatory mechanisms and clinical implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Yu","family":"Zeng","sequence":"first","affiliation":[{"name":"School of Rehabilitation, Sichuan Vocational College of Health and Rehabilitation","place":["Zigong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Rehabilitation, Sichuan Vocational College of Health and Rehabilitation","place":["Zigong, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7150\/ijms.124473","article-title":"Role of circular RNAs in liver diseases","volume":"23","author":"Alzahrani","year":"2026","journal-title":"Int. J. Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterology Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41420-025-02576-9","article-title":"Circular RNA profiling identifies circ_0001522, circ_0001278, and circ_0001801 as predictors of unfavorable prognosis and drivers of triple-negative breast cancer hallmarks","volume":"11","author":"Awata","year":"2025","journal-title":"Cell Death Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ncrna.2024.01.013","article-title":"CircRNAs: pivotal modulators of TGF-\u03b2 signalling in cancer pathogenesis","volume":"9","author":"Bhat","year":"2024","journal-title":"Non-coding RNA Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.omtn.2021.11.020","article-title":"hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA","volume":"27","author":"Cen","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/genes13050746","article-title":"Spatiotemporal regulation of circular RNA expression during liver development of Chinese Indigenous ningxiang pigs","volume":"13","author":"Chen","year":"2022","journal-title":"Genes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103042","DOI":"10.1016\/j.psj.2023.103042","article-title":"Dietary Morus alba L. leaf supplementation improves hepatic lipid accumulation of laying hens via downregulating CircACACA","volume":"102","author":"Chen","year":"2023","journal-title":"Poult. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jare.2022.08.007","article-title":"Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling","volume":"48","author":"Duan","year":"2023","journal-title":"J. Adv. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J. Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"118707","DOI":"10.1016\/j.lfs.2020.118707","article-title":"Circular RNAs in liver diseases: mechanisms and therapeutic targets","volume":"264","author":"Fu","year":"2021","journal-title":"Life Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"elaf005","DOI":"10.1093\/bfgp\/elaf005","article-title":"Recent advances in investigation of circRNA\/lncRNA-miRNA-mRNA networks through RNA sequencing data analysis","volume":"24","author":"Gao","year":"2025","journal-title":"Briefings Funct. Genomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: the yin and Yang of cellular nutrient sensing and growth control","volume":"31","author":"Gonz\u00e1lez","year":"2020","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3960197","DOI":"10.1155\/2017\/3960197","article-title":"circRNA_0046367 prevents hepatoxicity of lipid peroxidation: an inhibitory role against hepatic steatosis","volume":"2017","author":"Guo","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40104-025-01153-5","article-title":"A novel protein encoded by porcine circANKRD17 activates the PPAR pathway to regulate intramuscular fat metabolism","volume":"16","author":"He","year":"2025","journal-title":"J. Animal Sci. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI15593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investigation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-026-08450-5","article-title":"Circular RNAs in metabolic health: bridging the gap between molecular biology and therapy","volume":"17","author":"Huang","year":"2026","journal-title":"Cell Death Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J. Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2019.05.009","article-title":"CircACC1 regulates assembly and activation of AMPK complex under metabolic stress","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12951-021-01108-8","article-title":"A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/kjm2.12568","article-title":"Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c\/SIK2\/PI3K\/Akt axis","volume":"38","author":"Li","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2305902","DOI":"10.1002\/advs.202305902","article-title":"A mammalian conserved circular RNA CircLARP1B regulates hepatocellular carcinoma metastasis and lipid metabolism","volume":"11","author":"Li","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","article-title":"Peroxisome proliferator-activated receptors: a key link between lipid metabolism and cancer progression","volume":"43","author":"Li","year":"","journal-title":"Clin. Nutr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1011729","DOI":"10.1371\/journal.pgen.1011729","article-title":"Circular RNA profiling revealed an evolutionarily conserved circACACA promotes liver lipid metabolism, oxidative stress, and autophagy disorder in a ceRNA manner","volume":"21","author":"Li","year":"","journal-title":"PLOS Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"110988","DOI":"10.1016\/j.ygeno.2025.110988","article-title":"Mechanistic insights into GLP-1 receptor agonist-induced weight loss through ceRNA network analysis","volume":"117","author":"Li","year":"","journal-title":"Genomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ncrna.2025.04.005","article-title":"The role of non-coding RNA regulates stem cell programmed death in disease therapy","volume":"13","author":"Liao","year":"2025","journal-title":"Noncoding RNA Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1152\/ajpendo.00528.2019","article-title":"Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease","volume":"319","author":"Liu","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"154226","DOI":"10.1016\/j.phymed.2022.154226","article-title":"Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks","volume":"103","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/ani14060839","article-title":"Molecular mechanisms of circRNA\u2013miRNA\u2013mRNA interactions in the regulation of goose liver development","volume":"14","author":"Liu","year":"2024","journal-title":"Animals"},{"key":"B34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterology Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-024-06698-3","article-title":"The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications","volume":"15","author":"Ma","year":"2024","journal-title":"Cell Death Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","article-title":"5\u2032 UTR m6A promotes cap-independent translation","volume":"163","author":"Meyer","year":"2015","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e71052","DOI":"10.1111\/jcmm.71052","article-title":"Insights into circRNA-Mediated lipid metabolism in cancer progression","volume":"30","author":"Miao","year":"2026","journal-title":"J. Cell Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ncrna10010011","article-title":"Circular RNAs, noncoding RNAs, and N6-methyladenosine involved in the development of MAFLD","volume":"10","author":"Nakashima","year":"2024","journal-title":"Noncoding RNA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr. Berl."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","article-title":"Going circular: history, present, and future of circRNAs in cancer","volume":"42","author":"Pisignano","year":"2023","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s11658-023-00447-8","article-title":"The role of noncoding RNAs in metabolic reprogramming of cancer cells","volume":"28","author":"Safi","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","article-title":"Fatty liver disease: diagnosis and stratification","volume":"73","author":"Saiman","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12032-023-02275-4","article-title":"A therapeutical insight into the correlation between circRNAs and signaling pathways involved in cancer pathogenesis","volume":"41","author":"Saleh","year":"2024","journal-title":"Med. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"104942","DOI":"10.1016\/j.critrevonc.2025.104942","article-title":"Role of circular RNAs in regulating tumor microenvironment, epithelial mesenchymal transition, and resistance to cancer therapy","volume":"216","author":"Samad","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00018-023-04899-1","article-title":"Interference of a mammalian circRNA regulates lipid metabolism reprogramming by targeting miR-24-3p\/Igf2\/PI3K-AKT-mTOR and Igf2bp2\/Ucp1 axis","volume":"80","author":"Shao","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.plipres.2021.101117","article-title":"PARPs in lipid metabolism and related diseases","volume":"84","author":"Sz\u00e1nt\u00f3","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e70053","DOI":"10.1002\/biof.70053","article-title":"A comprehensive insight into the roles of exosomal circRNAs in metabolic syndrome","volume":"51","author":"Taherpour","year":"2025","journal-title":"BioFactors"},{"key":"B49","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol. Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","article-title":"CircRNAs: role in human diseases and potential use as biomarkers","volume":"12","author":"Verduci","year":"2021","journal-title":"Cell Death Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1872","DOI":"10.1002\/wrna.1872","article-title":"Current understandings and open hypotheses on extracellular circular RNAs","volume":"15","author":"Verwilt","year":"2024","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e100115","DOI":"10.1136\/egastro-2024-100115","article-title":"Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis","volume":"2","author":"Wade","year":"2024","journal-title":"eGastroenterology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1801","DOI":"10.1002\/ctm2.1801","article-title":"A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jhep.2024.11.052","article-title":"A read-through circular RNA RCRIN inhibits metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Wang","year":"2025","journal-title":"J. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"884037","DOI":"10.3389\/fgene.2022.884037","article-title":"Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"148879","DOI":"10.1016\/j.ijbiomac.2025.148879","article-title":"CircSETD2 impairs hepatic lipid homeostasis in metabolic dysfunction-associated fatty liver disease by binding CPS1","volume":"333","author":"Xie","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-023-01773-3","article-title":"A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer","volume":"22","author":"Xiong","year":"2023","journal-title":"Mol. Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1227150","DOI":"10.3389\/fimmu.2023.1227150","article-title":"An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1016\/j.cell.2025.08.007","article-title":"Hepatocyte metabolic adaptations during pregnancy and lactation","volume":"188","author":"Yang","year":"2025","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-022-05540-y","article-title":"CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export","volume":"14","author":"Yu","year":"2023","journal-title":"Cell Death Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12944-022-01740-9","article-title":"CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease","volume":"21","author":"Yuan","year":"2022","journal-title":"Lipids Health Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e13220","DOI":"10.1111\/obr.13220","article-title":"Circular RNAs in metabolism and metabolic disorders","volume":"22","author":"Zeng","year":"2021","journal-title":"Obes. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/biom13030560","article-title":"LncRNA and circRNA in patients with non-alcoholic fatty liver disease: a systematic review","volume":"13","author":"Zeng","year":"2023","journal-title":"Biomolecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41420-025-02833-x","article-title":"CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326\/FGF1 axis","volume":"12","author":"Zeng","year":"2026","journal-title":"Cell Death Discov."},{"key":"B66","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12885-018-4689-7","article-title":"Circular RNA: new star, new hope in cancer","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-020-0105-2","article-title":"The circFASN\/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/genes14030688","article-title":"Identification of circular RNA profiles in the liver of diet-induced Obese mice and construction of the ceRNA network","volume":"14","author":"Zhang","year":"2023","journal-title":"Genes (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ncrna.2024.03.004","article-title":"Unraveling the crosstalk: circRNAs and the wnt signaling pathway in cancers of the digestive system","volume":"9","author":"Zhang","year":"2024","journal-title":"Non-coding RNA Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s42003-024-05797-3","article-title":"Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p\/miR-9-5p-mediated TGF-\u03b2 signaling cascade","volume":"7","author":"Zhou","year":"2024","journal-title":"Commun. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1507\/endocrj.ej24-0008","article-title":"Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress","volume":"72","author":"Zhou","year":"2025","journal-title":"Endocr. J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"103023","DOI":"10.1016\/j.psj.2023.103023","article-title":"Transcriptome analysis of healthy and fatty liver revealed that inhibition of SLCO1B3 induces abnormal liver metabolism and lipid synthesis","volume":"102","author":"Zhu","year":"2023","journal-title":"Poult. Sci."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1831613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:10:16Z","timestamp":1781561416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1831613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":73,"alternative-id":["10.3389\/fgene.2026.1831613"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1831613","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1831613"}}